Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition.
about
Pivotal Importance of STAT3 in Protecting the Heart from Acute and Chronic Stress: New Advancement and Unresolved IssuesRemote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationHigh glucose concentration abrogates sevoflurane post-conditioning cardioprotection by advancing mitochondrial fission but dynamin-related protein 1 inhibitor restores these effectsDiabetic cardiomyopathy: pathophysiology and clinical featuresCobalt Chloride Upregulates Impaired HIF-1α Expression to Restore Sevoflurane Post-conditioning-Dependent Myocardial Protection in Diabetic Rats.Ischemic conditioning: the challenge of protecting the diabetic heart.Sevoflurane postconditioning protects rat hearts against ischemia-reperfusion injury via the activation of PI3K/AKT/mTOR signalingDecreased brain K(ATP) channel contributes to exacerbating ischemic brain injury and the failure of neuroprotection by sevoflurane post-conditioning in diabetic rats.Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection.Involvement of Glycogen Synthase Kinase-3β and Oxidation Status in the Loss of Cardioprotection by Postconditioning in Chronic Diabetic Male Rats.Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.N-Acetylcysteine Restores Sevoflurane Postconditioning Cardioprotection against Myocardial Ischemia-Reperfusion Injury in Diabetic Rats.Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism.Long-term insulin treatment restores cardioprotection induced by sufentanil postconditioning in diabetic rat heart.Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms.Diabetic inhibition of preconditioning- and postconditioning-mediated myocardial protection against ischemia/reperfusion injury.Oxidative stress and myocardial injury in the diabetic heartThe cardioprotection of the insulin-mediated PI3K/Akt/mTOR signaling pathway.Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes.Cardioprotection with halogenated gases: how does it occur?Discrepancy in calcium release from the sarcoplasmic reticulum and intracellular acidic stores for the protection of the heart against ischemia/reperfusion injury.Antioxidant N-acetylcysteine attenuates the reduction of Brg1 protein expression in the myocardium of type 1 diabetic rats.High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels.Cardioprotective effect of Notch signaling on the development of myocardial infarction complicated by diabetes mellitusInhibition of mammalian target of rapamycin protects against reperfusion injury in diabetic heart through STAT3 signaling.Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart.Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.Deferoxamine-activated hypoxia-inducible factor-1 restores cardioprotective effects of sevoflurane postconditioning in diabetic rats.Delayed remote ischemic preconditioning produces an additive cardioprotection to sevoflurane postconditioning through an enhanced heme oxygenase 1 level partly via nuclear factor erythroid 2-related factor 2 nuclear translocation.Pacing postconditioning: impact of pacing algorithm, gender, and diabetes on its myocardial protective effects.Chronic type-I diabetes could not impede the anti-inflammatory and anti-apoptotic effects of combined postconditioning with ischemia and cyclosporine A in myocardial reperfusion injury.Diabetes Worsens Skeletal Muscle Mitochondrial Function, Oxidative Stress, and Apoptosis After Lower-Limb Ischemia-Reperfusion: Implication of the RISK and SAFE Pathways?
P2860
Q26776101-84AF10CF-2477-4D58-BFDC-3E373825B35CQ28078462-3C0EE603-732C-42D9-A3AE-D52F781E2513Q28771345-8D870BC5-ED11-4883-BAE6-AE73C4481372Q30457504-9BDB6765-9A16-417E-9C61-332D0DFECB64Q33790008-FA051D4D-CA00-45DF-8FA3-9C0AD9C15C6CQ34457775-1250793C-2D63-40E2-BA49-5B1EB128E983Q34628699-F74AA86E-136A-41D3-8949-1B5A6F6E3D58Q34977129-C62FAD5B-2F7E-4DB1-A79C-5980CCBA3529Q35017049-18EBD059-3D90-490E-9B14-B3E93E3F6510Q36196031-8E897850-B077-4033-9940-67B48B671974Q36288965-AA63C5B1-75F4-4225-919F-28FDDD654CE2Q36405244-2FE22F9D-FBF8-4E61-8092-7B0B7773A829Q36689230-FF6A5E2D-AE79-438C-BBBB-CCD3AB486BA8Q37107072-DC24ADAA-6A00-4C46-9C4E-B1A83C6B7621Q37330288-824C1EAB-FEC7-414C-9416-8D2AF7A8A29DQ37913053-D25052EF-22BC-41D5-BBDA-7FDD6EC4A6CAQ38046547-4D239BE1-A05C-460C-8B74-70DA19D073F9Q38243667-8A8E7505-FBE5-4C9F-B144-200D76685661Q38903618-928B6102-BF66-41F7-A8E5-32FE40A250E8Q39180915-EBCB0B3A-9BB8-441B-B779-40905407CD41Q39205719-D59C4C17-4750-4181-955A-5655570836A9Q39668666-C1F74378-542D-434D-8995-93839EA50215Q42128148-14F1A9DF-A65E-4E69-86A3-4C59751049A2Q42158475-F69F8A78-772E-4128-9C94-589E4CF33642Q42376410-7E0C78DA-881F-417F-B609-F630FF615925Q45012762-BDB8041D-44C9-49A3-A4AC-A8732EC85EC9Q45065649-54041B7C-04DB-45D8-A424-4A0537276176Q46034115-CD0E49DA-8F0C-412A-A442-94A6F9D8B775Q46402109-4C59CB69-62C8-4C35-A844-DF5A31A2C67EQ47895659-E99887D1-6E29-417C-9EAA-46D966F2D0D4Q50243642-4E820061-F980-4CF7-8744-88BE78B2A84AQ51368591-0A324A53-9601-4CB2-8E56-452D0A5A9C86Q55008130-842BFB78-90C0-4091-B846-CEF945126198
P2860
Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Diabetes blockade of sevoflura ...... 3-kinase-mediated inhibition.
@en
Diabetes blockade of sevoflura ...... 3-kinase-mediated inhibition.
@nl
type
label
Diabetes blockade of sevoflura ...... 3-kinase-mediated inhibition.
@en
Diabetes blockade of sevoflura ...... 3-kinase-mediated inhibition.
@nl
prefLabel
Diabetes blockade of sevoflura ...... 3-kinase-mediated inhibition.
@en
Diabetes blockade of sevoflura ...... 3-kinase-mediated inhibition.
@nl
P2093
P1433
P1476
Diabetes blockade of sevoflura ...... 3-kinase-mediated inhibition.
@en
P2093
Benjamin Drenger
Israel A Ostrovsky
Jonathan H Axelrod
Michal Barak
Yael Nechemia-Arbely
P304
P356
10.1097/ALN.0B013E31820EFAFD
P407
P577
2011-06-01T00:00:00Z